PV Bulletin

Cosyland Kids Kitchen Step Stools recalled due to fall and entrapment hazards (Model CS0003)

Health Canada recalls Cosyland Kids Kitchen Step Stools due to collapse/tipping and entrapment risks; consumers to stop use and contact manufacturer for free repair parts.

Primary source: Health Canada

PV Impact Brief

Urgency: HighConfidence: high

What changed

Health Canada issued a recall for Cosyland Kids Kitchen Step Stools due to fall and entrapment hazards, requiring immediate cessation of use and provision of free repair parts.

Why it matters

The product poses serious risk of injury or death from tip-over, fall, or entrapment; similar products have caused injuries in the US.

Action needed

Immediately stop using the recalled stools, store away from children, and contact Wan Yi (866-677-3889 / customerservice-ca@cosyland.com) to request free repair parts (protective nets, stabilizing feet, instructions).

Relevant for
Regulatory Intelligence LeadSignal Management Lead
Processes impacted
Signal ManagementLabeling
Owner

Regulatory Intelligence Lead

Review cadence

Review in the next regulatory intelligence cycle.

Regulatory action details

Action type
Consumer product recall
Publication date
2026-06-05
Safety issue
The recalled Kids Kitchen Step Stools can collapse or tip over while in use, and a child's torso can fit through the openings, posing fall and entrapment hazards.

Affected products

  • Cosyland Kids Kitchen Step Stools
    SuzhouGongYeYuanQu Wan Yi Shen Jia MaoYiShangHang

PV internal implications

Immediately stop using the recalled product and contact the manufacturer to receive free repair parts.

View regulator source

Evidence and confidence

Confidence: highSource updated: Jun 5, 2026

Full briefing

Practical implication

Immediately stop using the recalled stools, store away from children, and contact Wan Yi (866-677-3889 / customerservice-ca@cosyland.com) to request free repair parts (protective nets, stabilizing feet, instructions).

Health Canada published a recall alert for Cosyland Kids Kitchen Step Stools (model CS0003) sold on Amazon.ca. The stools can collapse or tip over, and openings allow torso entrapment. No incidents reported in Canada; 25 US incidents with 8 injuries reported. Consumers must stop use and contact Wan Yi for free repair parts (18 units sold in Canada).

What changed: Health Canada issued a recall for Cosyland Kids Kitchen Step Stools due to fall and entrapment hazards, requiring immediate cessation of use and provision of free repair parts.

Why it matters: The product poses serious risk of injury or death from tip-over, fall, or entrapment; similar products have caused injuries in the US.

Practical implication: Immediately stop using the recalled stools, store away from children, and contact Wan Yi (866-677-3889 / customerservice-ca@cosyland.com) to request free repair parts (protective nets, stabilizing feet, instructions).

View original source

Published from the Firecrawl agent regulatory extraction pipeline.

#Safety Signals#Consumer product recall#Health Canada#safety_signal#firecrawl-agent#regulatory-extraction

Related updates for your role

publicTherapeutics Goods Administration · Australia · Updated Jul 20, 2026

Updates on ISO 14155 and N=1 Therapeutics Discussed by TGA

Urgency: High

Investigators need to modify trial protocols and safety reporting mechanisms in line with the latest ISO 14155 updates to ensure compliance for upcoming high-risk clinical trials.

Inspection ReadinessICSRRegulatory Intelligence Lead
SOP Impact2 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead, PV Quality Lead
verifiedRegulatory action: Notice
Read impact briefarrow_forward
publicMedicines and Healthcare products Regulatory Agency (MHRA) · United Kingdom · Updated May 23, 2026

MHRA confirms UK clinical trial safety reporting guidance is effective

Urgency: High

Safety lead to: (1) perform a UK-clinical-trial safety reporting gap assessment against MHRA’s effective guidance sections (MedDRA coding; AE/SAE; RSI governance; SUSARs; annual safety reporting; USMs; serious breaches; temporary suspension), (2) update controlled SOPs/WIs and training records to reflect “effective” status as of 28 Apr 2026, and (3) document deviations/gaps and open CAPA where needed for ongoing UK trials and new submissions.

ICSRCountry ComplianceRegulatory Intelligence Lead
SOP Impact4 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead, QPPV
verifiedRegulatory action: Guidance
Read impact briefarrow_forward
publicEuropean Medicines Agency (EMA) · European Union · Updated Jul 20, 2026

CHMP Draft Agenda for Public Consultation on Thalassaemia and Sickle Cell Disease Guidelines

Urgency: High

Sponsors and MAHs must review and align safety data collection and reporting protocols with the newly adopted guidelines while preparing for implementation of PRAC recommendations stemming from this meeting.

Signal ManagementICSRRegulatory Intelligence Lead
SOP Impact2 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead, Signal Management Lead
verifiedRegulatory action: Agenda
Read impact briefarrow_forward
publicSwissmedic · Switzerland · Updated Jul 17, 2026

Checklist for the Inspection of Medical Device Vigilance in Hospitals

Urgency: High

Healthcare facilities must utilize the new checklist during inspections to conduct gap analyses and ensure compliance with reporting requirements associated with their vigilance systems.

Inspection ReadinessRegulatory Intelligence Lead
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead, PV Quality Lead
verifiedRegulatory action: Checklist
Read impact briefarrow_forward